http://rdf.ncbi.nlm.nih.gov/pubchem/patent/UA-104128-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_071951dd7dfb2d38df0b292f2d09957f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-00 |
| filingDate | 2015-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94a97127d9cd97f736b7fac6747e3a73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cd0eb015babca8016d3e88887dd97cd |
| publicationDate | 2016-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | UA-104128-U |
| titleOfInvention | METHOD FOR TREATING ACUTE ISCHEMIC STROKE |
| abstract | A method of treating acute ischemic stroke involves the use of drugs, and against the background of traditional basic therapy, corvitin is prescribed at a course dose of 10.5 g / course and 1000 mg ceraxon for 10 days according to the following scheme: the initial dose of 0.5 g of corvitine is administered immediately after hospitalization, administration is repeated after 2 and 12 hours; from 2-x to 10th day, the drug is administered in a dose of 0.5 g twice a day with an interval of 12 hours; a single dose of corvitine 0.5 g is diluted in 50 ml of an isotonic sodium chloride solution and administered intravenously dropwise for 15-20 minutes, the course dose is 10.5 g. Also, from the first day of treatment, 1000 mg (4 ml) is administered daily. ceraxon in 200 ml of a 0.9% solution of sodium chloride from the 11th day of treatment, chewable Quertin tablets are prescribed once three times a day for one month. |
| priorityDate | 2015-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.